News from NYU Langone Health

NYU Langone Health Improves Annual Operating Margin To 3%. (Becker's Hospital Review)

Becker’s Hospital Review (11/18) NYU Langone Health reported an operating income for the fiscal year ending Aug. 31 that increased year-on-year, according to financial documents.

MTA Expected To Approve Congestion Plan. (WNBC-TV New York)

WNBC-TV (11/18) NYU Langone Health, one of the only major hospitals within New York’s congestion pricing zone, expressed concerns about Governor Hochul’s revised congestion pricing plan, which charges drivers $9 during peak hours and $2.25 during off-peak hours; a letter from Joseph J. Lhota, executive vice president and vice dean, chief financial office, chief of staff said, “almost 70 percent of patients receiving clinical care at NYU Langone Health in the zone reside outside of Manhattan,” emphasizing the potential impact on patient access, as the MTA board prepares to vote on the plan, which promises reduced traffic and increased transit funding.

Also reporting was WNBC-TV New York (11/18).

Meet Joe DiMeo The First Man To Undergo A Face And Double Hand Transplant; He Just Got Engaged. (Times of India)

The Times of India (11/18) Joe DiMeo, who survived a life-altering accident in 2018, underwent a groundbreaking 23-hour face and double hand transplant at NYU Langone Health in 2020, marking the world’s first successful surgery of its kind and restoring his ability to use his hands.

At Least One Person Dead Due To E.Coli Outbreak Linked To Organic Carrots. (NBC News Now-2)

NBC News Now-2 (11/18) Grimway Farm has recalled organic carrots due to a deadly E. coli outbreak, and Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, said, “It is the fourth E. coli outbreak of the year,” not that the strain is a “virulent one.”

Extended Dosing Intervals Possible With Aflibercept In Diabetic Macular Edema. (MedPage Today)

MedPage Today (11/18) Yasha S. Modi, MD, associate professor, Department of Ophthalmology, participated in a MedPage Today virtual roundtable discussing the 3-year results of the PHOTON study; Dr. Modi said, “I certainly think for those patients who get out to 20 weeks, especially 24 weeks, you start to wonder, can you switch these patients to a PRN basis?”

Routine Financial Toxicity Screening Feasible During Cancer Treatment. (Healio)

Healio (11/18) An interdisciplinary team led by Emeline Aviki, MD, MBA, clinical assistant professor, Department of Obstetrics and Gynecology, Perlmutter Cancer Center, found that routine screening for financial toxicity during active cancer treatment is feasible, using tools like the Comprehensive Score for Financial Toxicity (COST) and a health-related social risk checklist.

COVID-19 Virus Could Attack Cancer Cells And Shrink Tumors, New Study Suggests. (Fox News)

Fox News (11/18) Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, and senior medical analyst for Fox News, said that while a recent study published in the Journal of Clinical Investigation linking COVID-19 infection to cancer regression is “not a cancer cure and was only seen in mice,” it underscores the complex role viruses play in inflammation and immune system activation.

News from NYU Langone Hospital—Long Island

Laparoscopy May Offer Advantages To Laparotomy For Some Women With Ovarian Cancer. (Healio)

Healio (11/18) New research shows laparoscopy could present benefits over laparotomy for women with ovarian cancer, but Farr R. Nezhat, MD, adjunct professor, Department of Obstetrics and Gynecology, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, said, “To date, the feasibility and safety of laparoscopy have been demonstrated only in observational studies.”